InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

Current share price for RHT : $0.060 0.003 (5.26%)+

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$29 Appendix 4C - quarterly 29 Jan 2020 2:34PM $0.250 $0.060 fallen by 76%
$29 Appendix 3B and Secondary Trading Notice 13 Jan 2020 1:43PM $0.255 $0.060 fallen by 76.47%
$29 Change of Director's Interest Notice x 4 3 Dec 2019 1:47PM $0.195 $0.060 fallen by 69.23%
$29 Appendix 3B and Secondary Trading Notice 3 Dec 2019 1:47PM $0.195 $0.060 fallen by 69.23%
$29 Results of Meeting 28 Nov 2019 4:08PM $0.215 $0.060 fallen by 72.09%
$29 Resonance Health Partners with Siemens healthineers 28 Nov 2019 10:22AM $0.190 $0.060 fallen by 68.42%
$29 Investor Presentation November 2019 25 Nov 2019 11:07AM $0.175 $0.060 fallen by 65.71%
$29 New AI Tool for Automated Assessment of Liver Fat 21 Nov 2019 11:43AM $0.155 $0.060 fallen by 61.29%
$29 Resonance Health Files Provisional Patent 20 Nov 2019 12:50PM $0.135 $0.060 fallen by 55.56%
$29 Appendix 4C - quarterly 28 Oct 2019 9:45AM $0.145 $0.060 fallen by 58.62%
$29 Notice of Annual General Meeting/Proxy Form 25 Oct 2019 5:46PM $0.145 $0.060 fallen by 58.62%
$29 Updated Securities Trading Policy 22 Oct 2019 2:43PM $0.145 $0.060 fallen by 58.62%
$29 Annual Report to shareholders 22 Oct 2019 2:41PM $0.145 $0.060 fallen by 58.62%
$29 Appendix 4G and Corporate Governance Statement 22 Oct 2019 2:39PM $0.145 $0.060 fallen by 58.62%
$29 Full Year Statutory Accounts 27 Sep 2019 5:57PM $0.115 $0.060 fallen by 47.83%
$29 Preliminary Final Report 27 Aug 2019 11:17AM $0.105 $0.060 fallen by 42.86%
$29 Appendix 4C - quarterly 29 Jul 2019 9:58AM $0.125 $0.060 fallen by 52%
$29 Resonance Health contracted new clinical trials 19 Jul 2019 11:10AM $0.115 $0.060 fallen by 47.83%
$29 Appendix 3B and Secondary Trading Notice 16 Jul 2019 5:57PM $0.125 $0.060 fallen by 52%
$29 Secondary Trading Notice 1 May 2019 4:54PM $0.120 $0.060 fallen by 50%
$29 R&D Activities Update and Appendix 3B 30 Apr 2019 5:57PM $0.130 $0.060 fallen by 53.85%
$29 Customer Newsletter - April 2019 16 Apr 2019 10:05AM $0.170 $0.060 fallen by 64.71%
$29 Appendix 4C - quarterly 16 Apr 2019 10:02AM $0.170 $0.060 fallen by 64.71%
$29 Response to ASX Price and Volume Query 15 Apr 2019 4:26PM $0.170 $0.060 fallen by 64.71%
$29 Investor Presentation March 2019 25 Mar 2019 8:22AM $0.093 $0.060 fallen by 35.48%

226 - 250 of 532 results

Page 10 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.